Patents by Inventor Walter N. Shaw

Walter N. Shaw has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5716975
    Abstract: Provided are methods for treating hyperglycemia and Alzheimer's disease utilizing certain rhodanine derivatives. Certain of the rhodanine derivatives utilized in the instant methods are novel and, accordingly, such compounds and pharmaceutical formulations thereof are also provided.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: February 10, 1998
    Assignee: Eli Lilly and Company
    Inventors: Juliana M. Bue-Valleskey, David C. Hunden, Charles D. Jones, Jill A. Panetta, Walter N. Shaw
  • Patent number: 5661168
    Abstract: Provided is a method for treating hyperglycemia utilizing certain rhodanine derivatives. Certain of the rhodanine derivatives utilized in the instant method are novel and, accordingly, such compounds and pharmaceutical formulations thereof, are also provided.
    Type: Grant
    Filed: July 10, 1996
    Date of Patent: August 26, 1997
    Assignee: Eli Lilly and Company
    Inventors: Jill A. Panetta, Juliana Bue-Valleskey, David C. Hunden, Charles D. Jones, Walter N. Shaw
  • Patent number: 5523314
    Abstract: Provided are methods for treating hyperglycemia and Alzheimer's disease utilizing certain rhodanine derivatives. Certain of the rhodanine derivatives utilized in the instant methods are novel and, accordingly, such compounds and pharmaceutical formulations thereof are also provided.
    Type: Grant
    Filed: March 16, 1994
    Date of Patent: June 4, 1996
    Assignee: Eli Lilly and Company
    Inventors: Juliana M. Bue-Valleskey, David C. Hunden, Charles D. Jones, Jill A. Panetta, Walter N. Shaw
  • Patent number: 4845127
    Abstract: Optically active N-3-(4-substituted phenyl)propyl-.beta.-phenethanolamines are provided as well as pharmaceutical compositions containing such compounds. A method for effecting weight control in obese animals utilizing optically active phenethanolamine is disclosed. Novel intermediates useful in the preparation of optically active .beta.-phenethanolamines are provided.
    Type: Grant
    Filed: December 14, 1984
    Date of Patent: July 4, 1989
    Assignee: Eli Lilly and Company
    Inventors: Jack Mills, Klaus K. Schmiegel, Walter N. Shaw
  • Patent number: 4602044
    Abstract: .beta.-Phenethanolamines are useful as antiobesity agents.
    Type: Grant
    Filed: December 19, 1983
    Date of Patent: July 22, 1986
    Assignee: Eli Lilly and Company
    Inventors: Klaus K. Schmiegel, Walter N. Shaw
  • Patent number: 4391826
    Abstract: Optically active N-3-(4-substituted phenyl)propyl-.beta.-phenethanolamines are provided as well as pharmaceutical compositions containing such compounds. A method for effecting weight control in obese animals utilizing optically active phenethanolamines is disclosed. Novel intermediates useful in the preparation of optically active .beta.-phenethanolamines are provided.
    Type: Grant
    Filed: November 21, 1979
    Date of Patent: July 5, 1983
    Assignee: Eli Lilly and Company
    Inventors: Jack Mills, Klaus K. Schmiegel, Walter N. Shaw